MedPass International is the leading Medical Device CRO and Regulatory, Reimbursement Consultancy in Europe.

Our mission is to help our clients bring new medical technologies to market quickly and cost efficiently. We offer a full range of integrated services customized to each client’s needs. From early advice on regulatory and reimbursement strategies, through clinical trial design and execution, to assistance with market approval and reimbursement, MedPass can help. We also provide EU Authorized and Legal Representative services.

In the current environment, clinical evidence is the key to obtaining and maintaining approval for new medical technologies. MedPass is highly specialized in all aspects of medical device clinical trials from site selection to final study report. Our highly trained clinical staff are strategically located throughout Europe to be in close proximity to investigational sites. In addition we were the first medical device CRO to be fully certified to ISO 13485 and all of our clinical operating procedures adhere to ISO 14155 and FDA requirements.

Mission

OUR MISSION is to help clients bring new medical technologies to the market by accelerating successful achievement of their regulatory, clinical and reimbursement goals.

Experience

MedPass has 28 years experience supporting development of innovative medical technologies.

Staff

MedPass has over 100 highly qualified and experienced staff across Europe.

Latest news

MedPass is ISO 13485:2016 certified !

MedPass is ISO 13485:2016 certified !

Our Quality System is an important part of the services that we provide our clients. Therefore we are happy to…

Read more
ICON Acquires MedPass International

ICON Acquires MedPass International

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device…

Read more
Webinar: Navigating the “new normal” during COVID-19: A regulatory and clinical perspective for medical devices

Webinar: Navigating the “new normal” during COVID-19: A regulatory and clinical perspective for medical devices

Due to COVID-19, regulatory agencies are relaxing guidelines and shifting priorities to address shortages in diagnostics and respiratory devices. For…

Read more

GET IN TOUCH WITH MEDPASS